Marta Fonseca-Toledano
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer.
Journal: Molecular diagnosis & therapy
Published: March 05, 2026
NR3C1, LAX1, and RCAN3 as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer.
Journal: MedComm
Published: July 15, 2025
Glycolysis Inhibition Restores Immune Sensitivity in GSNOR-Deficient Colorectal Cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: April 16, 2025
Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients.
Journal: European journal of clinical investigation
Published: April 15, 2025
Unveilling the potential of liquid biopsy in pancreatic cancer for molecular diagnosis and treatment guidance.
Journal: Critical reviews in oncology/hematology
Published: February 26, 2025
Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement.
Journal: Clinical and translational medicine
Published: February 04, 2025
Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer.
Journal: BMC cancer
Published: July 05, 2024
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.
Journal: Cancer treatment reviews
Published: January 08, 2024
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 04, 2023
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects.
Journal: Biomarker research
Published: July 24, 2023
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 25, 2022
Last Updated: 09/26/2026